18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
Clinical trial NCT00775268 · TERMINATED
Trial details
- NCT number
- NCT00775268
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-29
- Primary completion
- 2014-10-23
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.